Bar Harbor Trust Services Abb Vie Inc. Transaction History

Bar Harbor Trust Services

100.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $0 - $0	0 New	0 $0
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $180,239 - $211,541	-2,098 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $153,930 - $205,981	2,098 New	2,098 $206,000
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $179,119 - $210,814	-2,322 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $7,784 - $9,601	100 Added 4.5%	2,322 $214,000

Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $2,693 - $3,186	-30 Reduced 1.33%	2,222 $206,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $157,302 - $200,923	2,252	2,252 $200,000

3,651

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bar Harbor Trust Services, based on Form 13F filings with the SEC.

Stay updated on Bar Harbor Trust Services with notifications on news.